Search BioPortfolio:
BioPortfolio
Web
Home
Careers
Conferences
Directory
Drug Discovery
Genes
InDepth
Marketing
News
Reports
Videos
Search
Contact
Thrombosis News and Headlines
Thrombosis news updated every 30 minutes from thousands of internet sites.
Sign-up to BioPortfolio's
Thrombosis
news alerts
.
Site Map
>
Biotechnology News
>
Health News
> Thrombosis
.
Landmark ATHENA Study Findings With Multaq(R)(dronedarone) Show 24% Reduction in Cardiovascular Hospitalisatio
Press Trust of India:
similar ...
Post-PCI thrombogenicity linked to race, gender, ischemia risk
MedWire News:
similar ...
Regado Biosciences' REG1 Anticoagulation System Study Results Published in the Journal of Thrombosis and Haemo
DiGiTAL50:
similar ...
Landmark ATHENA Study Findings With Multaq(R) (dronedarone) Shows 24% Reduction In Cardiovascular Hospitalizat
DiGiTAL50:
similar ...
Landmark ATHENA Study Findings With Multaq(R)(dronedarone) Show 24% Reduction in Cardiovascular Hosp
Antara Interactive:
similar ...
Regado Biosciences' REG1 Anticoagulation System Study Results Published In The Journal Of Thrombosis And Haemo
Medical News Today:
similar ...
Regado Biosciences' REG1 Anticoagulation System Study Results Published in the Journal of Thrombosis and Haemo
Pharma Live:
similar ...
International Endeavor Registry Reports Safety and Performance of Medtronic Drug-Eluting Stent in Diverse Pati
Genetic Engineering News:
similar ...
COMMUNIQUE: PR Newswire: BELG Landmark ATHENA Study Findings With Multaq(R)(dronedarone) Show 24% Reduction in
Belga Direct Press Releases:
similar ...
Landmark ATHENA Study Findings With Multaq(R)(dronedarone) Show 24% Reduction in Cardiovascular Hospitalisatio
Bolsamania:
similar ...
International Endeavor Registry Reports Safety and Performance of Medtronic Drug-Eluting Stent in Diverse Pati
Pharma Live:
similar ...
Landmark ATHENA Study Findings With Multaq (dronedarone) Shows 24% Reduction In Cardiovascular Hospitalization
Pharma Live:
similar ...
Landmark ATHENA Study Findings With Multaq(dronedarone) Show 24% Reduction in Cardiovascular Hospitalisation
Financial Post:
similar ...
Landmark ATHENA Study Findings With Multaq(R)(dronedarone) Show 24% Reduction in Cardiovascular Hospitalisatio
TradingMarkets:
similar ...
Landmark ATHENA Study Findings With Multaq(R) (dronedarone) Shows 24% Reduction In Cardiovascular Hospitalizat
Macro World Investor:
similar ...
Landmark ATHENA Study Findings With Multaq(R)(dronedarone) Show 24% Reduction in Cardiovascular Hospitalisatio
Canada NewsWire:
similar ...
Landmark ATHENA Study Findings With Multaq(R)(dronedarone) Show 24% Reduction in Cardiovascular Hospitalisatio
Yahoo! Canada:
similar ...
Landmark ATHENA Study Findings With Multaq(R)(dronedarone) Show 24% Reduction in Cardiovascular Hospitalisatio
Canadian Business Magazine:
similar ...
Landmark ATHENA Study Findings With Multaq(R)(dronedarone) Show 24% Reduction in Cardiovascular Hospitalisatio
Market Wire:
similar ...
Landmark ATHENA Study Findings With Multaq(R) (dronedarone) Shows 24% Reduction In Cardiovascular Hospitalizat
PR Newswire:
similar ...
